Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Alphatec Holdings, Inc. is a U.S.-based medical technology company focused on the design, development, and commercialization of products for spine surgery. The company operates within the spinal medical devices segment of the broader orthopedic and surgical healthcare industry, serving spine surgeons and hospitals with technologies aimed at improving clinical outcomes. Alphatec’s core business centers on providing integrated solutions that combine implants, surgical instruments, and procedural approaches.
The company’s primary revenue drivers are spinal fixation systems, interbody devices, biologics, and access technologies used in complex spine procedures. Alphatec is positioned as a technology-driven competitor emphasizing procedural innovation, surgeon workflow optimization, and lateral and minimally invasive spine surgery. Founded in 1990, the company has undergone several strategic transformations, with a significant shift beginning in 2018 toward focused investment in product innovation, surgeon education, and commercial infrastructure to drive sustained growth in the U.S. spine market.
Business Operations
Alphatec generates revenue through the sale of spine surgery products organized into its core operating platform, ATEC Spine, which encompasses fixation systems, interbody implants, deformity correction solutions, biologics, and surgical access tools. These offerings are designed to support a broad range of spine procedures, including degenerative, deformity, and complex revision surgeries. The company also integrates enabling technologies such as imaging-compatible instruments and approach-specific systems to differentiate its procedural solutions.
Operations are primarily concentrated in the United States, which represents the majority of revenue, with additional sales in select international markets. Alphatec controls proprietary implant designs, instrumentation platforms, and surgeon-support technologies, supported by a direct sales force and specialized clinical support teams. The company operates through wholly owned subsidiaries, including Alphatec Spine, Inc., which serves as the primary operating entity for commercial and development activities.
Strategic Position & Investments
Alphatec’s strategic direction centers on accelerating organic growth through continuous product innovation, expansion of its surgeon user base, and increased penetration in complex spine procedures. The company has prioritized investments in lateral and prone lateral surgical approaches, digital surgery platforms, and procedure-specific solutions that integrate implants, instruments, and techniques. These initiatives are intended to strengthen surgeon adoption and improve procedural efficiency and outcomes.
The company has also pursued targeted acquisitions to enhance its technology portfolio and commercial capabilities. Notable acquisitions include SafeOp Surgical, Inc., which expanded Alphatec’s intraoperative neuromonitoring capabilities, and EOS Imaging, which added low-dose 2D/3D imaging systems used in spine assessment and surgical planning. Alphatec continues to invest in emerging spine technologies and surgeon training programs as part of its long-term growth strategy.
Geographic Footprint
Alphatec is headquartered in Carlsbad, California, and maintains its primary operational and commercial presence in North America, particularly the United States, which is its largest and most strategically important market. The company’s U.S. footprint includes corporate offices, research and development facilities, and a nationwide direct sales organization supporting hospitals and ambulatory surgery centers.
Internationally, Alphatec has a growing presence in Europe, Asia-Pacific, and select other global markets through a combination of direct operations and distribution partners. While international revenue represents a smaller portion of total sales compared to the U.S., the company continues to view international expansion as a secondary growth opportunity supported by regulatory approvals and localized commercial investments.
Leadership & Governance
Alphatec’s leadership team emphasizes a growth-oriented strategy focused on innovation, commercial execution, and surgeon-centric product development. The company is led by executives with experience in spine and orthopedic medical device markets, supported by a board of directors overseeing governance, capital allocation, and long-term strategy.
Key executives include:
- Patrick S. Miles – Chairman of the Board and Chief Executive Officer
- Pedro L. Perez – President and Chief Operating Officer
- Robert C. McManus – Chief Financial Officer
- Peter F. Hoang – Executive Vice President, Global Operations
- Evan K. E. Lee – Executive Vice President, Global Marketing and Enablement
The leadership philosophy centers on disciplined execution, sustained investment in innovation, and building long-term relationships with spine surgeons through education and procedural differentiation.